Atlas Trials

Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma

Clinical trial NCT01467921 · UNKNOWN

Trial details

NCT number
NCT01467921
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma
Start date
2010-12-01
Primary completion
2012-02-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.